和铂医药首个NewCo实现部分退出,股价近三个月涨超300%

第一财经
26 Feb

2月26日早间,和铂医药(02142.HK)宣布一桩战略许可与合作协议,总付款将达3.95亿美元,受利好消息刺激,公司股价高开高走,午间报收5.89港元/股,涨幅6.13%。该协议由和铂医药孵化的创新型生物技术公司HBM Alpha Therapeutics Inc.(下称“HBMAT”)与一家业务合作伙伴达成,旨在共同推进针对多种疾病的新型促肾上腺皮质激素释放激素(CRH)靶向疗法。根据协议,该...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10